Cleopatra Hospital Co (CAI:CLHO) Moat Score: 0/10 (As of Jul. 02, 2026)


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
89 GF Score
Price E£16.30
GF Value E£13.90
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co Moat Score?

Cleopatra Hospital Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Cleopatra Hospital Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Cleopatra Hospital Co might have No Moat - No discernible moat.

Cleopatra Hospital Co  (CAI:CLHO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Cleopatra Hospital Co Moat Score Related Terms

CAI:CLHO
89GF Score
Cleopatra Hospital Co CAI:CLHO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£16.30 is trading 17.3% above its estimated GF Value™ of E£13.90. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • Moat Score: 0
  • GF Value™: E£13.90 vs. price of E£16.30 (17.3% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
89GF Score

Get the complete analysis for CAI:CLHO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£16.30
Price
E£13.90
GF Value